Federated Hermes, Inc. Icad Inc Transaction History

Federated Hermes, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$3.92 - $7.48 $2.77 Million - $5.29 Million	-707,053 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$12.57 - $21.22 $722,775 - $1.22 Million	57,500 Added 8.85%	707,053 $15 Million
Q2 2020 Aug 13, 2020	BUY	$6.63 - $12.85 $3.32 Million - $6.43 Million	500,000 Added 334.33%	649,553 $6.49 Million
Q1 2020 May 13, 2020	BUY	$6.94 - $14.42 $401,076 - $833,360	57,792 Added 62.98%	149,553 $1.1 Million
Q4 2019 Feb 14, 2020	BUY	$6.23 - $7.98 $571,671 - $732,252	91,761 New	91,761 $713,000

5.45M

3.6K

14.6K

Ticker ICAD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 25,333,900
Market Cap $42.6M
Description
iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, an...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.